DE69232875D1 - MHC-Konjugate zur Verbesserung der Autoimmunität. - Google Patents

MHC-Konjugate zur Verbesserung der Autoimmunität.

Info

Publication number
DE69232875D1
DE69232875D1 DE69232875T DE69232875T DE69232875D1 DE 69232875 D1 DE69232875 D1 DE 69232875D1 DE 69232875 T DE69232875 T DE 69232875T DE 69232875 T DE69232875 T DE 69232875T DE 69232875 D1 DE69232875 D1 DE 69232875D1
Authority
DE
Germany
Prior art keywords
improve autoimmunity
mhc
conjugates
mhc conjugates
autoimmunity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69232875T
Other languages
English (en)
Other versions
DE69232875T2 (de
Inventor
R Clark
D Sharma
L Lerch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coulter Pharmaceutical Inc
Original Assignee
Anergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/690,840 external-priority patent/US5260422A/en
Priority claimed from US07/869,293 external-priority patent/US5468481A/en
Application filed by Anergen Inc filed Critical Anergen Inc
Publication of DE69232875D1 publication Critical patent/DE69232875D1/de
Application granted granted Critical
Publication of DE69232875T2 publication Critical patent/DE69232875T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

DE69232875T 1991-04-23 1992-04-23 MHC-Konjugate zur Verbesserung der Autoimmunität. Expired - Fee Related DE69232875T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/690,840 US5260422A (en) 1988-06-23 1991-04-23 MHC conjugates useful in ameliorating autoimmunity
US07/869,293 US5468481A (en) 1988-06-23 1992-04-14 MHC class II-peptide conjugates useful in ameliorating autoimmunity
PCT/US1992/003391 WO1992018150A1 (en) 1991-04-23 1992-04-23 Mhc conjugates useful in ameliorating autoimmunity

Publications (2)

Publication Number Publication Date
DE69232875D1 true DE69232875D1 (de) 2003-01-30
DE69232875T2 DE69232875T2 (de) 2003-08-21

Family

ID=27104684

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232875T Expired - Fee Related DE69232875T2 (de) 1991-04-23 1992-04-23 MHC-Konjugate zur Verbesserung der Autoimmunität.

Country Status (3)

Country Link
EP (1) EP0630255B1 (de)
JP (1) JP2003231698A (de)
DE (1) DE69232875T2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2842570B1 (de) * 2007-03-07 2020-05-06 UTI Limited Partnership Zusammensetzungen und verfahren zur prävention und behandlung von autoimmunkrankheiten
WO2008116468A2 (en) 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP2167537A2 (de) 2007-07-03 2010-03-31 Dako Denmark A/S Zusammengestellte verfahren für die analyse und sortierung von proben
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
GB0919751D0 (en) * 2009-11-11 2009-12-30 King S College Hospital Nhs Fo Conjugate molecule
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
KR20160077202A (ko) 2013-11-04 2016-07-01 유티아이 리미티드 파트너쉽 지속적 면역요법을 위한 방법 및 조성물
BR112017023853A2 (pt) 2015-05-06 2018-07-17 Uti Limited Partnership composições de nanopartícula para terapia sustentada.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194425A (en) * 1988-06-23 1993-03-16 Anergen, Inc. Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
IL92629A0 (en) * 1989-12-10 1990-08-31 Yeda Res & Dev Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases
AU3220693A (en) * 1991-11-19 1993-06-15 Anergen, Inc. Mhc subunit conjugates useful in ameliorating deleterious immune responses

Also Published As

Publication number Publication date
EP0630255B1 (de) 2002-12-18
EP0630255A4 (de) 1995-04-19
EP0630255A1 (de) 1994-12-28
DE69232875T2 (de) 2003-08-21
JP2003231698A (ja) 2003-08-19

Similar Documents

Publication Publication Date Title
DE68908909D1 (de) Kabelbinder.
DE69126606D1 (de) Vakzine
DE69317474D1 (de) Abbaubarer Verbundstoff
MX9201770A (es) Mejoras relacionadas con las secciones de plastificacion.
DK0385610T3 (da) Konjugater
DE69114940D1 (de) Multifunktionsanzeigesystem.
DE69232875T2 (de) MHC-Konjugate zur Verbesserung der Autoimmunität.
FI924983A (fi) Polycykliska konjugat
DE59101215D1 (de) Kabelzugentlastung.
FI923238A0 (fi) Cysteinamid innehaollande permanent.
DE59102503D1 (de) Kanüle.
DE59107014D1 (de) 4-Cyano-3-fluorophenylester.
NO921807L (no) Brennstoffsammensetning
DE69105239D1 (de) Akarizide Zusammensetzung.
DE69229694D1 (de) Verbundwerkstoff
DE69300896D1 (de) Ziele.
ITMI921226A1 (it) Rincalzatrice
DE69123256D1 (de) Antigen-antikörperkonjugaten
ATE94266T1 (de) Kabelbinder.
FI742U1 (fi) Koppling foer kabeln till en svetsbraennare
NO920719D0 (no) Injiserbare s-adenosyl-l-metionin-holdige preparater
KR930014523U (ko) 괘지고리를 형성한 열쇠
ID1028B (id) Vaksin
SE9102907L (sv) Vaexttraagsystem inklusive delar
IS3737A7 (is) Hraðhrífa

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: COULTER PHARMACEUTICAL, INC., SEATTLE, WASH., US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee